289 related articles for article (PubMed ID: 9159144)
1. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.
Huard B; Mastrangeli R; Prigent P; Bruniquel D; Donini S; El-Tayar N; Maigret B; Dréano M; Triebel F
Proc Natl Acad Sci U S A; 1997 May; 94(11):5744-9. PubMed ID: 9159144
[TBL] [Abstract][Full Text] [Related]
2. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
Sakihama T; Smolyar A; Reinherz EL
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.
Bruniquel D; Borie N; Hannier S; Triebel F
Immunogenetics; 1998 Jul; 48(2):116-24. PubMed ID: 9634475
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.
Baixeras E; Huard B; Miossec C; Jitsukawa S; Martin M; Hercend T; Auffray C; Triebel F; Piatier-Tonneau D
J Exp Med; 1992 Aug; 176(2):327-37. PubMed ID: 1380059
[TBL] [Abstract][Full Text] [Related]
5. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding.
Moebius U; Pallai P; Harrison SC; Reinherz EL
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8259-63. PubMed ID: 8367491
[TBL] [Abstract][Full Text] [Related]
6. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
7. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
Hannier S; Triebel F
Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
[TBL] [Abstract][Full Text] [Related]
8. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
Huard B; Prigent P; Tournier M; Bruniquel D; Triebel F
Eur J Immunol; 1995 Sep; 25(9):2718-21. PubMed ID: 7589152
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.
Fleury S; Lamarre D; Meloche S; Ryu SE; Cantin C; Hendrickson WA; Sekaly RP
Cell; 1991 Sep; 66(5):1037-49. PubMed ID: 1889086
[TBL] [Abstract][Full Text] [Related]
10. T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.
Huard B; Prigent P; Pagès F; Bruniquel D; Triebel F
Eur J Immunol; 1996 May; 26(5):1180-6. PubMed ID: 8647185
[TBL] [Abstract][Full Text] [Related]
11. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
König R; Shen X; Germain RN
J Exp Med; 1995 Sep; 182(3):779-87. PubMed ID: 7650484
[TBL] [Abstract][Full Text] [Related]
12. Interactions of CD4 with MHC class II molecules, T cell receptors and p56lck.
Vignali DA; Doyle C; Kinch MS; Shin J; Strominger JL
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):13-24. PubMed ID: 7506833
[TBL] [Abstract][Full Text] [Related]
13. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
14. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
15. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.
Gao GF; Willcox BE; Wyer JR; Boulter JM; O'Callaghan CA; Maenaka K; Stuart DI; Jones EY; Van Der Merwe PA; Bell JI; Jakobsen BK
J Biol Chem; 2000 May; 275(20):15232-8. PubMed ID: 10809759
[TBL] [Abstract][Full Text] [Related]
16. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.
Demeure CE; Wolfers J; Martin-Garcia N; Gaulard P; Triebel F
Eur J Cancer; 2001 Sep; 37(13):1709-18. PubMed ID: 11527700
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.
Workman CJ; Dugger KJ; Vignali DA
J Immunol; 2002 Nov; 169(10):5392-5. PubMed ID: 12421911
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules.
Moebius U; Clayton LK; Abraham S; Diener A; Yunis JJ; Harrison SC; Reinherz EL
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12008-12. PubMed ID: 1465431
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.
Huard B; Tournier M; Hercend T; Triebel F; Faure F
Eur J Immunol; 1994 Dec; 24(12):3216-21. PubMed ID: 7805750
[TBL] [Abstract][Full Text] [Related]
20. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules.
Vignali DA; Moreno J; Schiller D; Hämmerling GJ
J Exp Med; 1992 Apr; 175(4):925-32. PubMed ID: 1552288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
